insurance changes for glp-1 drugs Upcoming Medications: What You Need to Know Costly GLP-1 Drugs are Rarely
Description
"Dosing should be regulated at every step or change by your physician
The makers of Ozempic state that the safety of this drug to unborn children is not known
The glucagon-like peptide-1 receptor (GLP-1R) is a key target for diabetes mellitus (DM) treatment, and GLP-1R agonists are pharmaceutical compounds employed in the treatment of DM
In particular, the burden of CVD will intensify, given that people with diabetes experience a two- to fourfold increased risk of developing ASCVD compared to those without [6] and that CVD accounts for two-thirds of deaths in the overweight/obese population [7]
Diabetes Res Clin Pract 186:109806
Our patients at Centra Internal Medicine noticed modest weight reduction within the first four weeks of treatment
